Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
about
An update on the diagnosis and treatment of Parkinson diseaseEffect of entacapone on colon motility and ion transport in a rat model of Parkinson's diseaseJejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safetyLevodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.IPX066 , a mixed immediate/sustained-release levodopa preparation for Parkinson's disease.Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics.Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Novel Levodopa Formulations for Parkinson's Disease.Placement of the AbbVie PEG-J tube for the treatment of Parkinson's disease in the interventional radiology suite.Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.Intrajejunal Infusion of Levodopa-Carbidopa Gel Can Continuously Reduce the Severity of Dropped Head in Parkinson's Disease.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.
P2860
Q30243899-73AA8126-5212-4AC4-88E2-B4CCCA736BABQ35221777-A5AC4EA6-0107-4859-92F0-39F4A58E6C01Q36025896-B661FC04-E6A5-41EA-9C63-F8F5BF5DAF66Q37698585-CEC26705-9C2C-49FD-9946-D5342F2F88D0Q38242125-5412D459-13F7-497F-A288-0D6D2CE295AAQ38275513-013BE150-34A4-46F0-A89C-B591BE7DA95DQ38748158-00E4B98E-74BF-4E6D-B72D-9EB2C4C2BD2AQ38981419-919A6D3B-9D93-4107-B024-2C66321DBDBBQ41092307-91C5925C-E62D-474E-8712-689C3E753B62Q42254695-F4A4DB70-518B-4186-9EB0-1538A4CC4461Q45394365-0FA6D862-27CE-4546-A03A-996F88087EFFQ47652358-9C8055CD-142B-4E2A-B1F2-C8425542F7EBQ47997995-C77B9AA6-96C0-4C87-9B24-F62C35E80A0CQ48425550-EE17959D-23B2-47E2-8570-E84C848C3D33
P2860
Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@ast
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@en
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@nl
type
label
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@ast
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@en
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@nl
prefLabel
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@ast
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@en
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@nl
P2860
P356
P1476
Population pharmacokinetics of ...... gel infusion vs. oral tablets
@en
P2093
Sandeep Dutta
P2860
P304
P356
10.1111/BCP.12324
P407
P577
2014-07-01T00:00:00Z